Kit to monitor lithium therapy
lithium therapy
Lithium, administered as lithium carbonate, is frequently used as a mood stabiliser in the treatment of bipolar disorder. It acts by enhancing reuptake of neurotransmitters thereby reducing their concentration in the neuronal junction; the result is a sedating effect on the central nervous system. Due to its narrow therapeutic and toxic range, it is important to monitor lithium levels in the serum to avoid toxicity, optimise therapeutic effect and ensure compliance. The new and improved Lithium kit from Randox is intended for the quantitative in vitro determination of lithium in serum and is suitable for use on a wide range of clinical analysers. The new reagent is liquid-stable for ease of use and offers an improved open vial stability of 14 days at 10oC. Other features include a wide measuring range of 0.281-3.00 mmol/L, excellent precision, traceability to the NIST reference method and limited interference from bilirubin, triglycerides and hemoglobin.
Randox Laboratories Ltd.
